Black people with multiple myeloma live longer than white patients with similar disease symptoms when both receive the same new and updated medical treatments, according to an analysis of the Surveillance, Epidemiology, and End Results (SEER) database. However, Black myeloma patients were less likely to receive such novel treatments than white individuals — even when matched for demographics, socioeconomic status, and co-existing medical conditions, the analysis showed. “Our findings reinforce the importance of equitable access…
April 01, 2022April 1, 2022